The mix of Keytruda and Lenvima plus chemotherapy didn't meet the first endpoint of general survival within the LEAP-015 trial for HER2-negative gastroesophageal...
The GPS immunotherapeutic agent demonstrated preliminary alerts of efficacy in AML.Amongst sufferers with acute myeloid leukemia (AML) in remission following second-line salvage remedy,...
Including Herceptin and Perjeta to chemotherapy elevated toxicity in sufferers with HER2+ gastric cancers.Herceptin plus chemotherapy confirmed numerical enhancements in general survival (OS)...
Martha Carlson acquired a analysis of metastatic breast most cancers in 2015. Learn all of Martha's blogs right here!I titled this weblog, “Strutting Into...
